CB
ALXN
Commerce Bank’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-4,853
| Closed | -$892K | – | 1205 |
|
|
2021
Q2 | $892K | Buy |
4,853
+20
| +0.4% | +$3.68K | 0.01% | 648 |
|
|
2021
Q1 | $739K | Buy |
4,833
+14
| +0.3% | +$2.14K | 0.01% | 687 |
|
|
2020
Q4 | $753K | Sell |
4,819
-545
| -10% | -$85.2K | 0.01% | 647 |
|
|
2020
Q3 | $613K | Sell |
5,364
-286
| -5% | -$32.7K | 0.01% | 633 |
|
|
2020
Q2 | $634K | Buy |
5,650
+1,439
| +34% | +$161K | 0.01% | 599 |
|
|
2020
Q1 | $378K | Buy |
4,211
+706
| +20% | +$63.4K | ﹤0.01% | 680 |
|
|
2019
Q4 | $379K | Buy |
3,505
+21
| +0.6% | +$2.27K | ﹤0.01% | 741 |
|
|
2019
Q3 | $341K | Buy |
3,484
+117
| +3% | +$11.5K | ﹤0.01% | 735 |
|
|
2019
Q2 | $441K | Buy |
3,367
+746
| +28% | +$97.7K | ﹤0.01% | 643 |
|
|
2019
Q1 | $355K | Sell |
2,621
-927
| -26% | -$126K | ﹤0.01% | 669 |
|
|
2018
Q4 | $345K | Buy |
3,548
+1,248
| +54% | +$121K | ﹤0.01% | 646 |
|
|
2018
Q3 | $320K | Buy |
2,300
+548
| +31% | +$76.2K | ﹤0.01% | 718 |
|
|
2018
Q2 | $218K | Buy |
+1,752
| New | +$218K | ﹤0.01% | 815 |
|
|
2016
Q1 | – | Sell |
-1,169
| Closed | -$223K | – | 814 |
|
|
2015
Q4 | $223K | Sell |
1,169
-260
| -18% | -$49.6K | ﹤0.01% | 731 |
|
|
2015
Q3 | $223K | Buy |
+1,429
| New | +$223K | ﹤0.01% | 732 |
|
|
2013
Q3 | – | Sell |
-2,452
| Closed | -$226K | – | 787 |
|
|
2013
Q2 | $226K | Buy |
+2,452
| New | +$226K | ﹤0.01% | 686 |
|